The Asia-Pacific Vascular Closure Devices Market was worth USD 1.79 billion in 2020 and is estimated to be growing at a CAGR of 9.5%, to reach USD 4.42 billion by 2025.
A small puncture is made to the femoral artery to conduct some diagnostics like an angiogram, and this puncture is sealed immediately to stop the blood flow using a metallic clip or collagen. These devices are called vascular closure devices. Vascular closure devices are preferred over manual compression due to the reduction in time and human effort required to conduct MC. VCDs increase the comfort levels for the patients and result in early discharge time. Recent developments introduced materials for VCDs that dissolve after a certain period.
Rising preference for minimally invasive surgeries and developing medical imaging are the significant factors propelling the vascular closure devices market. Increasing adoption of radiotherapy, which requires the use of medical imaging and the ease of use and reduced access site complications also drive the VCDs market.
Increasing costs of invasive VCDs and less adoption of technologies in developing countries are hindering the growth of the market.
This research report on the Asia-Pacific Vascular Closure Devices Market has been segmented and sub-segmented into the following categories:
Regional Analysis
The Asia Pacific VCDs market is rapidly growing due to the increase in expenditure on healthcare in countries like China and India, a huge patient base and increasing cardiovascular diseases. The increasing popularity of femoral artery cardiac catheterization, significant accomplishment rate of VCDs for improved patient comfort are the key driving factor for the APAC vascular closure device market. The high price of products, problems associated with VCD, lower acquisition rates of novel technologies is hampering the APAC vascular closure device market.
In 2019, Chinese vascular closure devices market dominated the Asia Pacific market and due to increasing prevalence of the cardiovascular disease in this region. In China, cardiovascular deaths are higher than the death rate due to cancer or other diseases. The total number of CVD patients in China in 2017 was 290 million, this factor driving the growth of Chinese VCDs market.
Japanese vascular closure devices market projected to be the fastest-growing region for the APAC market. It is due to the technological advancements resulting in the development of cost-effective vascular closure devices leading to significant obtaining rate for the devices in this region. The increasing compliances for vascular closure devices, supportive government authority, increasing demand for advanced treatment, rising research and clinical trials for vascular closure devices and growing market players offering innovative products is anticipated to drive the growth of the Vascular Closure Device market.
Promising companies leading in the APAC Vascular Closure Devices Market profiled in the report are W L. Gore & Associates, Merit Medical Systems, Inc., Abbott Vascular, Biotronik GMBH & CO.KG, St. Jude Medical, Cardinal Health, Medtronic, Boston Scientific Corporation, Cardival Medical, Inc., Essential Medical, Inc., TZ Medical, Inc. and Scion BioMedical.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Passive Approximators
5.1.2.1 Collagen Plugs
5.1.2.2 Sealant or Gel based Devices
5.1.2.3 Compression Assist Devices
5.1.3 Active Approximators
5.1.3.1 Suture-Based Devices
5.1.3.2 Clip-Based Devices
5.1.4 External Hemostatic Devices
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2 Access
5.2.1 Introduction
5.2.2 Femoral Access
5.2.3 Radial Access
5.2.4 Y-o-Y Growth Analysis, By Access
5.2.5 Market Attractiveness Analysis, By Access
5.2.6 Market Share Analysis, By Access
5.3 Procedure
5.3.1 Introduction
5.3.2 Interventional Cardiology
5.3.3 Interventional Radiology/Vascular Surgery
5.3.4 Y-o-Y Growth Analysis, By Procedure
5.3.5 Market Attractiveness Analysis, By Procedure
5.3.6 Market Share Analysis, By Procedure
5.4 End User
5.4.1 Introduction
5.4.2 Acute Care Facilities
5.4.3 Hospitals
5.4.4 Clinics
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.5 Market Attractiveness Analysis, By End User
5.4.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 Type
6.1.3.3 By Access
6.1.3.4 By Procedure
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Access
6.1.4.4 By Procedure
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Access
6.1.5.4 By Procedure
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Merit Medical Systems, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biotronik GMBH & CO.KG
8.3 Abbott Vascular
8.4 Cardinal Health
8.5 Medtronic
8.6 Boston Scientific Corporation
8.7 Cardival Medical, Inc.
8.8 Essential Medical, Inc.
8.9 W L. Gore & Associates
8.10 Scion BioMedical
8.11 St. Jude Medical
8.12 TZ Medical, Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
